We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Government Won't Let Huawei Enforce U.S. Patents
Read MoreHide Full Article
Huawei may be looking for an opportunity to talk to government officials, but the government is clearly not in the mood. Not only have officials made it clear that there are going to be no negotiations with the company, but it has also indicated that it will go to lengths to see that the company doesn’t create any mischief.
So when Huawei said Verizon (VZ - Free Report) owes it a billion dollars for infringement of 230 patents, Republican Senator Marco Rubio tweeted that the action was an “attempt by (Huawei) to retaliate against the U.S. by setting the stage for baseless, but costly, patent claims.”
He even followed that up with a proposed amendment to the National Defense Authorization Act (NDAA) that was earlier invoked to prevent federal purchases of Huawei products on the basis of national security concerns. The NDAA sets the broad policies for spending by the Department of Defense.
The current amendment seeks to prevent companies like Huawei that are placed on specified U.S. watch lists, from seeking legal resolution or damages in any U.S. court with respect to U.S. patents. While it still hasn’t been signed into law, this could happen quickly since both Republicans and Democrats generally agree on China concerns.
Huawei has of late been amassing U.S. patents, so the company may have been waiting to start claiming its rights anyway. Now that other revenue sources in the U.S. are drying up, it may have been exploring this route.
The truth is, the company is already feeling the pain of U.S. sanctions with officials confirming that international sales are down 40% (according to media reports). And although domestic sales have accelerated, and could see the company through the short term emergency, the inability to include American technology would cripple the company and limit it to second rate offerings for sale in the domestic market. Until it is able to come up with alternatives of its own that is. If at all it is able to create suitable alternatives, it could be several years before such technology is exported for gain.
The Chinese government could step in as part of its trade deal, something the U.S. has said it will entertain. Or it may not, if it is willing to take the risk of Huawei, which is a huge company, somehow battle it out on its own.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
The Government Won't Let Huawei Enforce U.S. Patents
Huawei may be looking for an opportunity to talk to government officials, but the government is clearly not in the mood. Not only have officials made it clear that there are going to be no negotiations with the company, but it has also indicated that it will go to lengths to see that the company doesn’t create any mischief.
So when Huawei said Verizon (VZ - Free Report) owes it a billion dollars for infringement of 230 patents, Republican Senator Marco Rubio tweeted that the action was an “attempt by (Huawei) to retaliate against the U.S. by setting the stage for baseless, but costly, patent claims.”
He even followed that up with a proposed amendment to the National Defense Authorization Act (NDAA) that was earlier invoked to prevent federal purchases of Huawei products on the basis of national security concerns. The NDAA sets the broad policies for spending by the Department of Defense.
The current amendment seeks to prevent companies like Huawei that are placed on specified U.S. watch lists, from seeking legal resolution or damages in any U.S. court with respect to U.S. patents. While it still hasn’t been signed into law, this could happen quickly since both Republicans and Democrats generally agree on China concerns.
Huawei has of late been amassing U.S. patents, so the company may have been waiting to start claiming its rights anyway. Now that other revenue sources in the U.S. are drying up, it may have been exploring this route.
The truth is, the company is already feeling the pain of U.S. sanctions with officials confirming that international sales are down 40% (according to media reports). And although domestic sales have accelerated, and could see the company through the short term emergency, the inability to include American technology would cripple the company and limit it to second rate offerings for sale in the domestic market. Until it is able to come up with alternatives of its own that is. If at all it is able to create suitable alternatives, it could be several years before such technology is exported for gain.
The Chinese government could step in as part of its trade deal, something the U.S. has said it will entertain. Or it may not, if it is willing to take the risk of Huawei, which is a huge company, somehow battle it out on its own.
Recommendations
National wireless communications stocks are hot right now, so you can take your pick of Verizon, GCI Liberty , Gogo (GOGO - Free Report) and T-Mobile U.S. (TMUS - Free Report) , all of which have a Zacks Rank #2 (Buy). Or you can pick Zacks #1-ranked United States Cellular Corp. (USM - Free Report) , or simply check out the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>